Acquired circulating anticoagulant disorder
Acquired circulating anticoagulant syndrome is an acquired coagulation factor inhibitor that can directly act on a specific coagulation factor and affect the coagulation of blood, causing bleeding tendency.
-
Site of disease:
whole body -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Bleeding tendency joint swelling intra-articular bleeding coagulopathy portosystemic collateral circulation
Related Drugs
Human fibrinogen
Indication: 1. Congenital hypofibrinogenemia or deficiency. 2. Acquired hypofibrinogenemia: severe liver damage; liver cirrhosis; disseminated intravascular coagulation; postpartum hemorrhage and coagulation disorders caused by fibrinogen deficiency due to major surgery, trauma or internal bleeding.
Manufacturer:
Nuoyi Biopharmaceutical Co., Ltd.
Human fibrinogen
Indication: 1. Congenital hypofibrinogenemia or deficiency. 2. Acquired hypofibrinogenemia: severe liver damage; liver cirrhosis; disseminated intravascular coagulation; postpartum hemorrhage and coagulation disorders caused by fibrinogen deficiency due to major surgery, trauma or internal bleeding.
Manufacturer:
Harbin Pesfico Biopharmaceutical Co., Ltd.